The first Humacyte trade was made in Q4 2021.
Since then Jim Simons bought shares six more times and sold shares on five occasions. The investor sold all their shares in Q3 2024 and doesn't own any shares in Humacyte anymore.
Avg closing price
Price range
Sold -600k shares
Q3 2024
Avg closing price
$6.45
Price range
$5.11
-
$9.46
Increased shares by 693.0% (+525k shares)
Q2 2024
Avg closing price
$5.20
Price range
$2.87
-
$9.10
Sold 20.4% shares (-19.4k shares)
Q1 2024
Avg closing price
$3.36
Price range
$2.57
-
$4.84
Sold 11.5% shares (-12.4k shares)
Q4 2023
Avg closing price
$2.57
Price range
$1.99
-
$3.12
Increased shares by 50.1% (+35.9k shares)
Q3 2023
Avg closing price
$3.31
Price range
$2.75
-
$4.48
Increased shares by 50.1% (+23.9k shares)
Q2 2023
Avg closing price
$3.60
Price range
$2.86
-
$4.97
Increased shares by 100.4% (+23.9k shares)
Q1 2023
Avg closing price
$2.84
Price range
$2.11
-
$3.25
Sold 88.6% shares (-184k shares)
Q4 2022
Avg closing price
$3.04
Price range
$2.02
-
$3.62
Increased shares by 1773.9% (+197k shares)
Q3 2022
Avg closing price
$3.83
Price range
$3.26
-
$5.14
Sold 76.4% shares (-36k shares)
Q2 2022
Avg closing price
$5.56
Price range
$3.21
-
$7.86
Increased shares by 218.2% (+32.3k shares)
Q1 2022